SII Current Affairs - 2020

SII directed to suspend recruitment for Oxford vaccine trial

Drugs Controller General of India (DCGI) which is country’s apex drug regulator has directed Serum Institute of India SII to suspend the new recruitments which were about to happen for recent phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine till further orders. Why the SII is asked to suspend recruitment for vaccine Read More…

India to start trial of Oxford COVID-19 vaccine

India’s top drug regulatory body DCGI (The Drugs Controller General of India) finally gave green signal to Serum Institute of India (SII) for conducting phase II and III clinical trials of Astra Zeneca vaccine developed by the Oxford University against coronavirus disease. The approval came after scrutiny was done based on the recommendations of the Read More…